Scott Sutherland, MD
Division Chief

Dr. Scott Sutherland's research interests are focused on acute kidney injury (AKI), continuous renal replacement therapy (CRRT), and critical care nephrology.  He is particularly interested in AKI and CRRT epidemiology as well as the concept of renal recovery following AKI events.  His work has helped define the association between AKI and poorer outcomes including greater mortality, longer hospital stays, and the subsequent development of chronic kidney dysfunction.  He continues to participate in a number of national/international AKI collaboratives including the Prospective Pediatric Acute Kidney Injury (ppAKI) Research Group, the Assessment of Worldwide AKI, Renal Angina and Epidemiology (AWARE) study, and Nephrotoxic Injury Negated by Just-in-time Action (NINJA).  He co-leads the Solutions for Patient Safety (SPS) NINJA program, and sits on the AWARE steering committee, the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) IT subcommittee, and both the American Society of Pediatric Nephrology Research and Clinical Affairs committees.  He is a longstanding faculty member of the annual AKI & CRRT International Conference and the bi-annual Pediatric AKI symposium.  His research strives to refine our ability to identify and diagnose AKI and to improve outcomes in these children.

Mary Leonard, MD, MSCE
Chair of Pediatrics

Mary was named Pediatrics Department Chair in 2016 after joining the Division in 2014 as Associate Dean of Maternal and Child Health Research. Her multidisciplinary research program is focused primarily on the impact of chronic diseases on bone metabolism and nutrition, with an emphasis on changes in body composition and skeletal density and structure during growth, and in the context of chronic kidney disease and glucocorticoid therapy.  She has maintained continuous NIH funding for nearly two decades.  

She is the Founding Director of the new Stanford Assessment of Bone and Muscle across the Ages (SAMBA) Center.  The Center houses state-of-the-art equipment for studies of bone microarchitecture, body composition, and muscle strength.  As evidence of her success as a mentor, she recently renewed her NIDDK K24 award that supports these activities.  She also served/serves as the primary mentor on multiple NIH and Foundation career development grants, including (3) F32, (1) K07, and (5) K23 awards.  She is also Co-Director of the weekly clinical research in nephrology work-in-progress seminar that is attended by fellows, junior faculty and biostatisticians.

Paul C. Grimm, MD
Fellowship Program Director
Medical Director of Pediatric Kidney Transplantation

Fellows who join our training program have broad access to participate in a full range of research and scholarly activity. I have been involved in basic transplant research for 20 years. My work has been focused on the pathogenesis of subclinical rejection, and chronic allograft damage (chronic rejection). I have developed extensive expertise in computerized image analysis to quantitate chronic graft changes such as fibrosis. My lab has served as a core lab for multicenter trials on assessment of allograft pathology and is positioned to conduct vital research on the issue of diagnosis and quantitation of inflammation and rejection. Stanford has an long history of performing pediatric and adult transplants, a dedicated and productive pathologist and an extensive biopsy database and clinical follow-up data.

Cynthia Wong, MD
Medical Director of Pediatric Dialysis

Dr. Cynthia Wong is the Medical Director of Pediatric Dialysis and conducts clinical research in chronic kidney disease.  She is center PI for the Chronic Kidney Disease in Children and participates in Standardized Care to Improve Outcomes in Pediatric Endstage Kidney Disease (SCOPE) collaborative, Renal Anhydramnios Fetal Therapy (RAFT trial), and North American Pediatric Renal Trials and Collaborative Studies (NAPRTCs). 

Diversity Statement

Our division and fellowship program are committed to recruiting and supporting those who identify as underrepresented in medicine based on factors such as race, ethnicity, socioeconomic status, disability, sexual orientation, gender identity, and more. We are committed to creating a culture of openness, acceptance, and celebration of our collective differences and experiences.